rosiglitazone has been researched along with Lipid Metabolism Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Q; Niu, YJ; Tao, RY; Tian, JY; Ye, F; Zhu, HB; Zhu, P | 1 |
| Arias, P; Astort, F; Berg, G; Cymeryng, CB; Di Gruccio, JM; Martinez Calejman, C; Mercau, ME; Pandolfi, M; Repetto, EM; Sanchez, R; Schreier, L | 1 |
2 other study(ies) available for rosiglitazone and Lipid Metabolism Disorders
| Article | Year |
|---|---|
Improvement on lipid metabolic disorder by 3'-deoxyadenosine in high-fat-diet-induced fatty mice.
Topics: Animals; Area Under Curve; Cordyceps; Deoxyadenosines; Dietary Fats; Disease Models, Animal; Fenofibrate; Glucose; Glucose Clamp Technique; Glucose Intolerance; Insulin; Insulin Resistance; Lipid Metabolism; Lipid Metabolism Disorders; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Obesity; Phytotherapy; Rosiglitazone; Thiazolidinediones; Weight Gain | 2010 |
Insulin sensitization with a peroxisome proliferator-activated receptor γ agonist prevents adrenocortical lipid infiltration and secretory changes induced by a high-sucrose diet.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Animals; Corticosterone; Dietary Sucrose; Energy Intake; Hormones; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism Disorders; Male; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Triglycerides | 2012 |